Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-03-01
著者
-
MARUTA Atsuo
Department of Hematology, Kanagawa Cancer Center
-
Takahashi Masatomo
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Takahashi Masatomo
聖マリアンナ医科大学 血液･腫瘍内科
-
谷脇 雅文
Department Of Environmental Systems Engineering Kochi University Of Technology
-
FUJISAWA Shin
Yokohama City University Medical Center
-
Taniwaki Masafumi
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Tanaka Masatsugu
Department Of Hematology Kanagawa Cancer Center
-
Tanimoto Mitsune
Okayama Univ. Hospital Okayama Jpn
-
Tanimoto Mitsune
岡山大学 医歯総研究 第2内科
-
Takahashi Masatomo
St. Marianna Univ. School Of Medicine Kawasaki Jpn
-
Murata Takashi
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Taniwaki M
Celgene Kk
-
Tanimoto Mitsune
名古屋大学 第1内科
-
ITO Satomi
Department of Hematology, Kanagawa Cancer Center
-
Kanamori Heiwa
Department Of Hematology Kanagawa Cancer Center
-
Kanamori Heiwa
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Tsuji Takashi
Department Of Hematology Kanagawa Cancer Center
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University
-
Ishigatsubo Yoshiaki
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Maruta Atsuo
Department Of Hematology Kanagawa Cancer Center
-
Maruta A
Kanagawa Cancer Center Yokohama City Jpn
-
Tanimoto Mitsune
First Department Of Internal Medicine Nagoya University School Of Medicine
-
TAKASAKI Hirotaka
Department of Hematology, Kanagawa Cancer Center
-
Takasaki Hirotaka
Department Of Hematology Kanagawa Cancer Center
-
Hyo Rie
Department Of Hematology Yokohama City University Medical Center
-
Ito Satomi
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Sakai Rika
Department Of Hematology Kanagawa Cancer Center
-
Tomita Naoto
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Tomita Naoto
Department Of Hematology Graduate School Of Medicine Yokohama City University
-
Ohshima Rika
Department Of Hematology Kanagawa Cancer Center
-
Hagihara Maki
Department Of Hematology Yokohama City University Medical Center
-
Watanabe Reina
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Tachibana Takayoshi
Department Of Hematology Kanagawa Cancer Center
-
Tachibana Takayoshi
Department Of Hematology Shizuoka Red Cross Hospital
-
Fujita Hiroyuki
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Tomit Naoto
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Fujita Hiroyuki
Department Of Environmental Immuno-dermatology Yokohama City University Graduate School Of Medicine
-
Fujisawa Shin
Department Of Hematology Yokohama City University Medical Center
-
Kuwabara Hideyuki
Department Of Hematology Kanagawa Cancer Center
-
Sakai Rika
Department Of Hematology Yokohama City University Medical Center
-
Ishigatsubo Yoshiaki
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Tabata Masahiro
The Department Of Internal Medicine Ii Okayama University Medical School
-
Takabayashi Maki
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Fujita Hiroyuki
Department Of Hematology Shizuoka Red Cross Hospital
-
NUMATA Ayumi
Department of Hematology, Kanagawa Cancer Center
-
Numata Ayumi
Department Of Hematology Kanagawa Cancer Center
-
TSUJI Takashi
Department of Hematology, Kanagawa Cancer Center
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- 特集「顕微鏡法による材料開発のための微細構造研究最前線(8)-照射効果の解明と耐照射材料および新素材開発をめざして-」の企画にあたって
- A study of rasburicase for the management of hyperuricemia in pediatric patients with newly diagnosed hematologic malignancies at high risk for tumor lysis syndrome
- 24pYF-11 GaSb, InSbの電子線照射効果(格子欠陥・ナノ構造(半導体),領域10,誘電体,格子欠陥,X線・粒子線,フォノン物性)
- 点欠陥の自己組織化的挙動を利用した微細構造形成法
- イオン照射で導入される点欠陥を利用したナノセル構造の形成
- イオン照射によって導入された点欠陥によるセル構造の形成
- イオン照射による半導体微細セル構造の自己組織化形成
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Surface Sink Effects on Void Formation in GaSb and InSb under Ion Irradiation
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
- Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Multiple Myeloma : Results from the Japan Myeloma Study Group
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Case-control study of leukemia and diagnostic radiation exposure
- Outcome of Non-T-Cell-Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation from Family Donors in Children and Adolescents
- Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
- Multiple extra-articular synovial cysts complicated with rheumatoid arthritis
- Systemic sclerosis and pseudomesotheliomatous adenocarcinoma of the lung
- Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
- Successful cord blood transplantation for mycosis fungoides.
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Good Prognosis of Patients With Acute Promyelocytic Leukemia Who Achieved Second Complete Remission (CR) With a New Retinoid, Am80, After Relapse From CR Induced by All-trans-Retionic Acid
- The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma : a propensity score matching analysis
- Phase II and pharmacokinetic study of thalidomide in Japanese patients with relapsed/refractory multiple myeloma
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- Risk of Neutropenic Fever and Early Infectious Complications after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Diseases
- Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- The presence of mature granulocytes/monocytes derived from leukemic cells in MLL-associated leukemia
- Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
- A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Asymptomatic Patients with Acute Leukemias and Malignant Lymphomas Found in Ningen Dock
- Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
- Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
- Calcineurin Inhibitor-Induced Irreversible Neuropathic Pain after Allogeneic Hematopoietic Stem Cell Transplantation
- Thrombotic thrombocytopenic purpura associated with myelodysplastic syndrome
- Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin
- IP-1 Confirmation of the Essential Role of LTB4 in Airway Hyperresponsiveness Using LTA4H-Deficient Mice
- Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemia
- Cyclin-dependent kinase inhibitor SU9516 enhances sensitivity to methotrexate in human T-cell leukemia Jurkat cells
- Anti-AnWj antibody in a case with non-Hodgkin lymphoma
- Dexamethasone Reduces the Risk of Bortezomib-Induced Pulmonary Complications in Japanese Myeloma Patients
- Relapse of idiopathic thrombocytopenic purpura caused by influenza A virus infection : a case report
- 白滝鉱山が地域にもたらしたもの
- 「わが国の鉱業の過去, 現在そして未来」の企画にあたって
- Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
- Detection of NOTCH1 Mutations in Adult T-Cell Leukemia/Lymphoma and Peripheral T-Cell Lymphoma
- Scrotal Ulcers Arising during Treatment with All-trans Retinoic Acid for Acute Promyelocytic Leukemia
- Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions
- Expression of heme oxygenase-1 in human leukemic cells and its regulation by transcriptional repressor Bach1
- Cerebral venous sinus thrombosis after allogeneic stem cell transplantation
- Clinical Significance of Fragmented Red Cells after Allogeneic Bone Marrow Transplantation
- Acute Lymphoblastic Leukemia with t(1;9;22)(q32;q34;q11)
- Posttransplantation Epstein-Barr Viral Meningitis in a Patient With Chronic Myelogenous Leukemia
- De novo Acute Myelogenous Leukemia with Trilineage Myelodysplasia Associated with t(8:21)(q22;q22)
- Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System
- A case of systemic lupus erythematosus complicated with pneumatosis cystoides intestinalis
- Use of musculoskeletal ultrasound in Japan : a survey of practicing rheumatologists
- Renal vein lymphoma embolism in non-Hodgkin lymphoma
- Void Formation and Structure Change Induced by Heavy Ion Irradiation in GaSb and InSb
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells
- Allogeneic peripheral blood progenitor cell transplantation conditioned with anti-thymocyte globulin for treatment of graft failure after allogeneic bone marrow transplantation
- Successful treatment of a Jehovah's Witness with Acute promyleocytic leukemia
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Formation of Defect Structure on Ge Surface by Ion Irradiation at Controlled Substrate Temperature
- Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies
- Successful treatment with gemtuzumab ozogamicin and donor lymphocyte infusion for acute myeloid leukemia relapsing after allogeneic stem cell transplantation
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Intravascular B-cell lymphoma with hypercalcemia as the initial presentation
- Prognostic factors in patients aged 50 years or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancy
- Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia : continuity from carrier status to smoldering ATL
- Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma